The Kiwi company has gained customers from a purpose-built B2B platform accessible behind the Chinese firewall.
Partnership with VitaKey could yield new products within five years.
Enthusiasm marks both IPO and ASX/NZX debut.
UPDATED: (15.11.2021) NZX-listed Green Cross Health and Pacific Equity Partners no longer in running for Tāmaki Health.
IPO stock priced at US$15 rose to high of US$32.44 before settling back.
Country's largest fuel retailer maintains full-year earnings guidance.
Purpose-built rental units are both a good investment and an answer to the housing crisis, it says.
Research reveals the slow Covid response is damaging our international reputation.
Cherri Global to raise up to $15m in share offer.
But the deal will see AMP pay A$141m to Resolution.